医学
血脂异常
心理干预
预防保健
重症监护医学
疾病
公共卫生
内科学
病理
精神科
作者
Adham El Sherbini,Robert S. Rosenson,Mahmoud Al Rifai,Hafeez Ul Hassan Virk,Zhen Wang,Salim S. Virani,Benjamin S. Glicksberg,Carl J. Lavie,Chayakrit Krittanawong
标识
DOI:10.1016/j.pcad.2024.03.002
摘要
Artificial intelligence (AI) is a field of study that strives to replicate aspects of human intelligence into machines. Preventive cardiology, a subspeciality of cardiovascular (CV) medicine, aims to target and mitigate known risk factors for CV disease (CVD). AI's integration into preventive cardiology may introduce novel treatment interventions and AI-centered clinician assistive tools to reduce the risk of CVD. AI's role in nutrition, weight loss, physical activity, sleep hygiene, blood pressure, dyslipidemia, smoking, alcohol, recreational drugs, and mental health has been investigated. AI has immense potential to be used for the screening, detection, and monitoring of the mentioned risk factors. However, the current literature must be supplemented with future clinical trials to evaluate the capabilities of AI interventions for preventive cardiology. This review discusses present examples, potentials, and limitations of AI's role for the primary and secondary prevention of CVD.
科研通智能强力驱动
Strongly Powered by AbleSci AI